These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| þ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| o | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
New York
(State or Other Jurisdiction of Incorporation or organization) |
16-0961359
(IRS Employer Identification No.) |
|
|
2200 Rand Building, Buffalo, NY
(Address of Principal executive offices) |
14203
(Zip Code) |
| Large accelerated filer o | Accelerated filer o | Non-accelerated filer þ | Smaller reporting company o | |||
| (Do not check if a smaller reporting company) |
|
|
||||||||
| 3 | ||||||||
|
|
||||||||
| 3 | ||||||||
|
|
||||||||
| 4 | ||||||||
|
|
||||||||
| 5 | ||||||||
|
|
||||||||
| 6 | ||||||||
|
|
||||||||
| 7 | ||||||||
|
|
||||||||
| 10 | ||||||||
|
|
||||||||
| 20 | ||||||||
|
|
||||||||
| 27 | ||||||||
|
|
||||||||
| 27 | ||||||||
|
|
||||||||
|
|
||||||||
| 28 | ||||||||
|
|
||||||||
| 28 | ||||||||
|
|
||||||||
| 28 | ||||||||
|
|
||||||||
| 28 | ||||||||
|
|
||||||||
| 28 | ||||||||
|
|
||||||||
| 28 | ||||||||
|
|
||||||||
| 29 | ||||||||
|
|
||||||||
| Exhibit 31.1 | ||||||||
| Exhibit 31.2 | ||||||||
| Exhibit 32.1 | ||||||||
| Exhibit 32.2 | ||||||||
2
| Item 1. | Financial Statements and Supplementary Data |
| September 30, | ||||||||
| 2011 | December 31, | |||||||
| (Unaudited) | 2010 | |||||||
|
ASSETS
|
||||||||
|
Investments at fair value (identified cost: 9/30/11 - $12,208,977; 12/31/10 - $13,573,041)
|
$ | 21,696,992 | $ | 19,364,625 | ||||
|
Cash and cash equivalents
|
4,504,418 | 11,698,653 | ||||||
|
Interest receivable (net of allowance: 9/30/11 - $122,000; 12/31/10 - $158,245)
|
1,319,424 | 1,051,848 | ||||||
|
Prepaid income taxes
|
637,290 | 414,745 | ||||||
|
Other assets
|
2,048,144 | 2,561,389 | ||||||
|
|
||||||||
|
|
||||||||
|
Total assets
|
$ | 30,206,268 | $ | 35,091,260 | ||||
|
|
||||||||
|
|
||||||||
|
LIABILITIES AND STOCKHOLDERS EQUITY (NET ASSETS)
|
||||||||
|
Liabilities:
|
||||||||
|
Debentures guaranteed by the SBA
|
$ | 4,000,000 | $ | 10,000,000 | ||||
|
Deferred tax liability
|
2,146,611 | 1,044,315 | ||||||
|
Accounts payable and accrued expenses
|
224,910 | 990,477 | ||||||
|
Deferred revenue
|
| 5,650 | ||||||
|
|
||||||||
|
Total liabilities
|
6,371,521 | 12,040,442 | ||||||
|
|
||||||||
|
Stockholders equity (net assets):
|
||||||||
|
Common stock, $.10 par; shares authorized 10,000,000; shares issued 6,863,034
|
686,304 | 686,304 | ||||||
|
Capital in excess of par value
|
10,581,789 | 10,581,789 | ||||||
|
Accumulated net investment loss
|
(1,913,879 | ) | (1,648,118 | ) | ||||
|
Undistributed net realized gain on investments
|
8,510,719 | 9,833,282 | ||||||
|
Net unrealized appreciation on investments
|
6,017,020 | 3,644,767 | ||||||
|
Treasury stock, at cost, 44,100 shares
|
(47,206 | ) | (47,206 | ) | ||||
|
|
||||||||
|
Net assets (per share 9/30/11 - $3.50 , 12/31/10 - $3.38)
|
23,834,747 | 23,050,818 | ||||||
|
|
||||||||
|
|
||||||||
|
Total liabilities and stockholders equity (net assets)
|
$ | 30,206,268 | $ | 35,091,260 | ||||
|
|
||||||||
3
| Three months | Three months | Nine months | Nine months | |||||||||||||
| ended | ended | ended | ended | |||||||||||||
| September 30, | September 30, | September 30, | September 30, | |||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||
|
Investment income:
|
||||||||||||||||
|
Interest from portfolio companies
|
$ | 170,209 | $ | 189,915 | $ | 549,845 | $ | 523,921 | ||||||||
|
Interest from other investments
|
8,828 | 6,770 | 26,909 | 15,959 | ||||||||||||
|
Dividend and other investment income
|
254,300 | 26,220 | 324,856 | 62,511 | ||||||||||||
|
Other income
|
7,100 | 4,525 | 14,680 | 11,853 | ||||||||||||
|
|
||||||||||||||||
|
|
440,437 | 227,430 | 916,290 | 614,244 | ||||||||||||
|
|
||||||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Salaries
|
118,750 | 495,050 | 356,250 | 725,150 | ||||||||||||
|
Employee benefits
|
22,700 | 26,802 | 88,384 | 110,939 | ||||||||||||
|
Directors fees
|
12,750 | 15,750 | 65,250 | 73,500 | ||||||||||||
|
Professional fees
|
45,519 | 27,573 | 122,323 | 118,264 | ||||||||||||
|
Stockholders and office operating
|
27,104 | 24,701 | 101,703 | 96,625 | ||||||||||||
|
Insurance
|
7,800 | 9,656 | 27,646 | 29,476 | ||||||||||||
|
Corporate development
|
15,773 | 15,584 | 48,510 | 39,351 | ||||||||||||
|
Other operating
|
2,070 | 2,977 | 12,264 | 11,005 | ||||||||||||
|
|
||||||||||||||||
|
|
252,466 | 618,093 | 822,330 | 1,204,310 | ||||||||||||
|
Interest on SBA obligations
|
184,080 | 143,151 | 479,199 | 427,155 | ||||||||||||
|
Bad debt recovery
|
| | | (5,983 | ) | |||||||||||
|
|
||||||||||||||||
|
Total expenses
|
436,546 | 761,244 | 1,301,529 | 1,625,482 | ||||||||||||
|
|
||||||||||||||||
|
Investment gain (loss) before income taxes
|
3,891 | (533,814 | ) | (385,239 | ) | (1,011,238 | ) | |||||||||
|
Income tax expense (benefit)
|
18,809 | (219,963 | ) | (119,478 | ) | (387,747 | ) | |||||||||
|
|
||||||||||||||||
|
Net investment loss
|
(14,918 | ) | (313,851 | ) | (265,761 | ) | (623,491 | ) | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Realized and unrealized gain (loss) on investments:
|
||||||||||||||||
|
Realized gain (loss) on sales and dispositions
|
(1 | ) | 4,311,499 | (2,074,131 | ) | 4,311,499 | ||||||||||
|
Income tax expense (benefit)
|
| 1,536,869 | (751,568 | ) | 1,536,869 | |||||||||||
|
|
||||||||||||||||
|
Net realized gain (loss) on investments
|
(1 | ) | 2,774,630 | (1,322,563 | ) | 2,774,630 | ||||||||||
|
Unrealized appreciation on investments:
|
||||||||||||||||
|
Beginning of period
|
7,956,016 | 8,785,064 | 5,791,584 | 9,528,226 | ||||||||||||
|
End of period
|
9,488,015 | 4,535,718 | 9,488,015 | 4,535,718 | ||||||||||||
|
|
||||||||||||||||
|
Change in unrealized appreciation before
income taxes
|
1,531,999 | (4,249,346 | ) | 3,696,431 | (4,992,508 | ) | ||||||||||
|
Deferred income tax expense (benefit)
|
544,840 | (1,571,940 | ) | 1,324,178 | (1,801,737 | ) | ||||||||||
|
|
||||||||||||||||
|
Net increase (decrease) in unrealized
appreciation
|
987,159 | (2,677,406 | ) | 2,372,253 | (3,190,771 | ) | ||||||||||
|
|
||||||||||||||||
|
Net realized and unrealized gain (loss) on investments
|
987,158 | 97,224 | 1,049,690 | (416,141 | ) | |||||||||||
|
|
||||||||||||||||
|
Net increase (decrease) in net assets from operations
|
$ | 972,240 | ($216,627 | ) | $ | 783,929 | ($1,039,632 | ) | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Weighted average shares outstanding
|
6,818,934 | 6,818,934 | 6,818,934 | 6,818,934 | ||||||||||||
|
Basic and diluted net increase (decrease) in net assets from operations per
share
|
$ | 0.14 | ($0.03 | ) | $ | 0.11 | ($0.15 | ) | ||||||||
4
| Nine months | Nine months | |||||||
| ended | ended | |||||||
| September 30, | September 30, | |||||||
| 2011 | 2010 | |||||||
|
Cash flows from operating activities:
|
||||||||
|
Net increase (decrease) in net assets from operations
|
$ | 783,929 | $ | (1,039,632 | ) | |||
|
Adjustments to reconcile net increase (decrease) in
net assets to net cash used in operating activities:
|
||||||||
|
Depreciation and amortization
|
94,744 | 31,168 | ||||||
|
Original issue discount accretion
|
(37,000 | ) | | |||||
|
Change in interest receivable allowance
|
(36,245 | ) | | |||||
|
(Increase) decrease in unrealized appreciation of
investments
|
(3,696,431 | ) | 4,992,508 | |||||
|
Deferred tax expense (benefit)
|
1,102,296 | (1,432,154 | ) | |||||
|
Net realized loss (gain) on portfolio investments
|
2,074,131 | (4,311,499 | ) | |||||
|
Non-cash conversion of debenture interest
|
(72,285 | ) | (342,897 | ) | ||||
|
Changes in operating assets and liabilities:
|
||||||||
|
(Increase) decrease in interest receivable
|
(231,331 | ) | 184,636 | |||||
|
Decrease (increase) in other assets
|
418,500 | (14,206 | ) | |||||
|
Increase in prepaid income taxes
|
(222,545 | ) | | |||||
|
Decrease in income taxes payable
|
| (240,994 | ) | |||||
|
(Decrease) increase in accounts payable and
accrued expenses
|
(765,567 | ) | 89,240 | |||||
|
Decrease in deferred revenue
|
(5,650 | ) | (1,353 | ) | ||||
|
|
||||||||
|
Total adjustments
|
(1,377,383 | ) | (1,045,551 | ) | ||||
|
|
||||||||
|
Net cash used in operating activities
|
(593,454 | ) | (2,085,183 | ) | ||||
|
|
||||||||
|
Cash flows from investing activities:
|
||||||||
|
Investments originated
|
(1,171,944 | ) | (2,830,000 | ) | ||||
|
Proceeds from sale of portfolio investments
|
| 4,655,379 | ||||||
|
Proceeds from loan repayments
|
571,163 | 90,606 | ||||||
|
Capital expenditures
|
| (846 | ) | |||||
|
|
||||||||
|
Net cash (used) provided by investing activities
|
(600,781 | ) | 1,915,139 | |||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Repayment of SBA debentures
|
(6,000,000 | ) | | |||||
|
Proceeds from SBA debentures
|
| 900,000 | ||||||
|
Origination costs to SBA
|
| (21,825 | ) | |||||
|
|
||||||||
|
Net cash (used) provided by financing activities
|
(6,000,000 | ) | 878,175 | |||||
|
|
||||||||
|
|
||||||||
|
Net (decrease) increase in cash and cash equivalents
|
(7,194,235 | ) | 708,131 | |||||
|
Cash and cash equivalents:
|
||||||||
|
Beginning of period
|
11,698,653 | 9,417,236 | ||||||
|
|
||||||||
|
End of period
|
$ | 4,504,418 | $ | 10,125,367 | ||||
|
|
||||||||
5
| Three months | Three months | Nine months | Nine months | |||||||||||||
| ended | ended | ended | ended | |||||||||||||
| September 30, | September 30, | September 30, | September 30, | |||||||||||||
| 2011 | 2010 | 2011 | 2010 | |||||||||||||
|
|
||||||||||||||||
|
Net assets at beginning of period
|
$ | 22,862,507 | $ | 22,382,876 | $ | 23,050,818 | $ | 23,205,881 | ||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net investment loss
|
(14,918 | ) | (313,851 | ) | (265,761 | ) | (623,491 | ) | ||||||||
|
Net realized (loss) gain on dispositions of investments
|
(1 | ) | 2,774,630 | (1,322,563 | ) | 2,774,630 | ||||||||||
|
Net increase(decrease) in unrealized appreciation
|
987,159 | (2,677,406 | ) | 2,372,253 | (3,190,771 | ) | ||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net increase (decrease) in net assets from operations
|
972,240 | (216,627 | ) | 783,929 | (1,039,632 | ) | ||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Net assets at end of period
|
$ | 23,834,747 | $ | 22,166,249 | $ | 23,834,747 | $ | 22,166,249 | ||||||||
|
|
||||||||||||||||
6
| (a) | (b) | Per | ||||||||||||||||||
| Company, Geographic Location, Business | Date | (c) | (d)(f) | Share | ||||||||||||||||
| Description, (Industry) and Website | Type of Investment | Acquired | Equity | Cost | Value | of Rand | ||||||||||||||
|
|
||||||||||||||||||||
|
Non-Control/Non-Affiliate Investments: (j)
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Chequed.com, Inc. (g)
Saratoga Springs, NY. Predictive employee selection and development software. (Software) www.chequed.com |
$500,000 convertible promissory notes at 8% due December 31, 2012. | 11/18/10 | 0 | % | $ | 500,000 | $ | 500,000 | $ | .07 | ||||||||||
|
|
||||||||||||||||||||
|
Liazon Corporation (e)(g)
Buffalo, NY. Employee benefits solution company. (Health Benefits Provider) www.liazon.com |
120,000 Series C-1 preferred shares.
546,667 Series C-2 preferred shares. |
11/9/10 | 4 | % | 858,199 | 1,000,000 | .15 | |||||||||||||
|
|
||||||||||||||||||||
|
Mezmeriz, Inc. (g)
Ithaca, NY. Developer of micro mirror technology that replaces silicon with carbon fibers in micro-electronic mechanical systems (MEMS) enabling efficient, wide-angle, Pico projectors to be embedded in mobile devices. (Electronics Developer) www.mezmeriz.com |
141,125 Series A preferred shares. | 1/9/08 | 4 | % | 121,509 | 121,509 | .02 | |||||||||||||
|
|
||||||||||||||||||||
|
Rheonix, Inc.
Ithaca, NY. Developer of microfluidic testing devices including channels, pumps, reaction vessels, & diagnostic chambers, for testing of small volumes of chemicals and biological fluids. (Manufacturing) www.rheonix.com |
9,676 common shares.
(g) 694,015 Series A preferred shares. 50,593 common shares. |
10/29/09 | 4 | % | 753,000 | 889,000 | .12 | |||||||||||||
|
|
||||||||||||||||||||
|
Somerset Gas Transmission Company, LLC (e)
Columbus, OH. Natural gas transportation company. (Oil and Gas) www.somersetgas.com |
26.5337 units. | 7/10/02 | 3 | % | 719,097 | 786,748 | .12 | |||||||||||||
|
|
||||||||||||||||||||
|
Synacor Inc. (g)
Buffalo, NY. Develops provisioning platforms for aggregation and delivery of content and services across multiple digital devices. (Software) www.synacor.com |
234,558 Series A preferred shares.
600,000 Series B preferred shares. 240,378 Series C preferred shares. 897,438 common shares. |
11/18/02 | 4 | % | 1,349,479 | 5,700,000 | .84 | |||||||||||||
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Subtotal Non-Control/Non-Affiliate Investments
|
$ | 4,301,284 | $ | 8,997,257 | $ | 1.32 | ||||||||||||||
|
|
||||||||||||||||||||
|
Affiliate Investments: (k)
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Carolina Skiff LLC (e)(g)
Waycross, GA. Manufacturer of fresh water, ocean fishing and pleasure boats. (Manufacturing) www.carolinaskiff.com |
$985,000 Class A preferred membership interest at 14%. Redeemable December
23, 2012. $500,000 subordinated promissory note at 14% due December 31, 2016. 6.0825% class A common membership interest.
(i) Interest receivable $1,263,369 |
1/30/04 | 7 | % | $ | 1,500,000 | $ | 1,500,000 | $ | .22 | ||||||||||
|
|
||||||||||||||||||||
|
EmergingMed.com,
Inc. (e)(g)
New York, NY. Cancer clinical trial matching and referral service. (Software) www.emergingmed.com |
$675,045 senior subordinated note at 8% due January 19, 2013. Warrants for 8% of common stock. | 12/19/05 | 8 | % | 675,046 | 675,046 | .10 | |||||||||||||
7
| (a) | (b) | Per | ||||||||||||||||||
| Company, Geographic Location, Business | Date | (c) | (d)(f) | Share | ||||||||||||||||
| Description, (Industry) and Website | Type of Investment | Acquired | Equity | Cost | Value | of Rand | ||||||||||||||
|
|
||||||||||||||||||||
|
Microcision
LLC (e)(g)
Philadelphia, PA. Custom manufacturer of medical and dental implants. (Manufacturing). www.microcision.com |
$1,500,000 subordinated promissory note at 5%, 6% deferred interest due December 31, 2013. 15% class A common membership interest. | 9/24/09 | 15 | % | 1,654,565 | 1,654,565 | .24 | |||||||||||||
|
|
||||||||||||||||||||
|
Mid America Brick & Structural Clay
Products, LLC(g)
Mexico, MO. Manufacturer of face brick for residential and commercial construction. (Manufacturing). www.midamericabrick.com |
19.524 membership units. | 6/1/10 | 19 | % | 800,000 | 800,000 | .12 | |||||||||||||
|
|
||||||||||||||||||||
|
SOMS Technologies, LLC (g)
Valhalla, NY. Produces and markets the microGreen Extended Performance Oil Filter. (Auto Parts Developer) www.microgreenfilter.com |
5,959,490 Series B membership units. | 12/2/08 | 10 | % | 472,632 | 528,348 | .08 | |||||||||||||
|
|
||||||||||||||||||||
|
Ultra Scan Corporation
Amherst, NY. Biometrics application developer of ultrasonic fingerprint technology. (Electronics Hardware/Software) www.ultra-scan.com |
536,596 common shares.
107,104 Series A-1 preferred shares. (g) 95,284 Series A-1 preferred shares. |
12/11/92 | 2 | % | 938,164 | 1,203,000 | .18 | |||||||||||||
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Subtotal Affiliate Investments
|
$ | 6,040,407 | $ | 6,360,959 | $ | .94 | ||||||||||||||
|
|
||||||||||||||||||||
|
Control Investments (l)
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Advantage 24/7 LLC (g)
Williamsville, NY. Marketing program for wine and spirits dealers. (Marketing Company) |
50% Membership interest. | 12/30/10 | 50 | % | $ | 100,000 | $ | 100,000 | $ | .02 | ||||||||||
|
|
||||||||||||||||||||
|
Gemcor II, LLC (e)(g)(h)
West Seneca, NY. Designs and sells automatic riveting machines used in the assembly of aircraft components. (Manufacturing) www.gemcor.com |
$500,000 subordinated promissory note at 15% due December 1, 2014. 25 membership units. Warrant to purchase 6.25 membership units. | 6/28/04 | 31 | % | 842,435 | 6,042,435 | .89 | |||||||||||||
|
|
||||||||||||||||||||
|
G-TEC
Natural Gas Systems
Buffalo, NY. Manufactures and distributes systems that allow natural gas to be used as an alternative fuel to gases. (Manufacturing) www.gas-tec.com |
21.6% Class A membership interest.
8% cumulative dividend. |
8/31/99 | 22 | % | 400,000 | 100,000 | .01 | |||||||||||||
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
Subtotal Control Investments
|
$ | 1,342,435 | $ | 6,242,435 | $ | .92 | ||||||||||||||
|
|
||||||||||||||||||||
|
Other Investments
|
Various | $ | 524,851 | $ | 96,341 | $ | 0 | |||||||||||||
|
|
||||||||||||||||||||
|
|
||||||||||||||||||||
|
|
Total portfolio investments | $ | 12,208,977 | $ | 21,696,992 | $ | 3.18 | |||||||||||||
|
|
||||||||||||||||||||
8
9
10
| | Rand and Rand SBIC to engage in certain related party transactions that the Corporation would otherwise be permitted to engage in as a BDC if its component parts were organized as a single corporation; |
| | Rand, as a BDC, and Rand SBIC, as its BDC/SBIC subsidiary, to meet asset coverage requirements for senior securities on a consolidated basis; and |
| | Rand SBIC, as a BDC/SBIC subsidiary of Rand as a BDC, to file Exchange Act reports on a consolidated basis as part of Rands Exchange Act reports. |
11
| N-54A | Election to Adopt Business Development Company status | ||
| DEF-14A | Definitive Proxy Statement submitted to shareholders | ||
| Form 10-K | Annual Report on Form 10-K for the year ended December 31, 2010 | ||
| Form 10-Q | Quarterly Report on Form 10-Q for the quarters ended June 30, 2011, March 31, 2011, and September 30, 2010 | ||
| Form N-23C-1 | Reports by closed-end investment companies of purchases of their own securities |
12
13
14
| | Loan and debt securities are generally valued at the price the security would command in order to provide a yield to maturity equivalent to the current yield of similar debt securities. A loan or debt instrument may be reduced in value if it is judged to be of poor quality and collection is in doubt. A loan or debt security may also be valued based on the estimated proceeds from the sale of a portfolio company at its estimated fair value. |
| | Equity securities may be valued using the market approach or income approach. The market approach uses observable prices and other relevant information generated by similar market transactions. It may include the use of market multiples derived from a set of comparables to assist in pricing the investment. Additionally, the Corporation adjusts valuations if a subsequent significant equity financing has occurred that includes a meaningful portion of the financing by a sophisticated, unrelated new investor. The income approach employs a cash flow and discounting methodology to value an investment. |
15
| Fair Value Measurements at Reported Date Using | ||||||||||||||||
| Quoted Prices in | Significant | Other Significant | ||||||||||||||
| Active Markets for | Observable | Unobservable | ||||||||||||||
| September 30, | Identical Assets | Inputs | Inputs | |||||||||||||
| Description | 2011 | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
|
|
||||||||||||||||
|
Loan investments
|
$ | 342,435 | | | $ | 342,435 | ||||||||||
|
|
||||||||||||||||
|
Debt investments
|
3,403,111 | | | 3,403,111 | ||||||||||||
|
|
||||||||||||||||
|
Equity investments
|
17,951,446 | | | 17,951,446 | ||||||||||||
|
|
||||||||||||||||
|
Total Venture Capital Investments
|
$ | 21,696,992 | $ | 0 | $ | 0 | $ | 21,696,992 | ||||||||
|
|
||||||||||||||||
| Fair Value Measurements at Reported Date Using | ||||||||||||||||
| Quoted Prices in | Significant Other | Significant | ||||||||||||||
| Active Markets for | Observable | Unobservable | ||||||||||||||
| December 31, | Identical Assets | Inputs | Inputs | |||||||||||||
| Description | 2010 | (Level 1) | (Level 2) | (Level 3) | ||||||||||||
|
|
||||||||||||||||
|
Loan investments
|
$ | 413,597 | | | $ | 413,597 | ||||||||||
|
|
||||||||||||||||
|
Debt investments
|
3,595,326 | | | 3,595,326 | ||||||||||||
|
|
||||||||||||||||
|
Equity investments
|
15,355,702 | | | 15,355,702 | ||||||||||||
|
|
||||||||||||||||
|
Total Venture Capital Investments
|
$ | 19,364,625 | $ | 0 | $ | 0 | $ | 19,364,625 | ||||||||
|
|
||||||||||||||||
16
| Fair Value Measurements Using Significant | ||||||||||||||||
| Unobservable Inputs (Level 3) | ||||||||||||||||
| Venture Capital Investments | ||||||||||||||||
| Loan | Debt | Equity | ||||||||||||||
| Description | Investments | Investments | Investments | Total | ||||||||||||
|
Beginning Balance, December 31, 2010,
of Level 3 Assets
|
$ | 413,597 | $ | 3,595,326 | $ | 15,355,702 | $ | 19,364,625 | ||||||||
|
|
||||||||||||||||
|
Realized Gains or Losses included in
net change in net assets from
operations
|
||||||||||||||||
|
Associates Interactive (Associates)
|
| | (293,518 | ) | (293,518 | ) | ||||||||||
|
Niagara Dispensing Technologies, Inc.
(Niagara Dispensing)
|
| (498,828 | ) | (1,281,785 | ) | (1,780,613 | ) | |||||||||
|
|
||||||||||||||||
|
Total Realized Losses
|
| (498,828 | ) | (1,575,303 | ) | (2,074,131 | ) | |||||||||
|
|
||||||||||||||||
|
Unrealized gains or losses included in
net change in net assets from
operations
|
||||||||||||||||
|
Associates
|
| | 293,518 | 293,518 | ||||||||||||
|
Liazon Corporation (Liazon)
|
| | 141,801 | 141,801 | ||||||||||||
|
Niagara Dispensing
|
| 447,328 | 1,281,785 | 1,729,113 | ||||||||||||
|
Synacor, Inc. (Synacor)
|
| | 1,531,999 | 1,531,999 | ||||||||||||
|
|
||||||||||||||||
|
Total Unrealized Gains and Losses
|
| 447,328 | 3,249,103 | 3,696,431 | ||||||||||||
|
|
||||||||||||||||
|
Purchases of Securities/Changes to
Securities/Non-cash conversions
|
||||||||||||||||
|
Chequed.com, Inc. (Chequed)
|
| 250,000 | | 250,000 | ||||||||||||
|
Microcision LLC (Microcision)
|
| 72,285 | | 72,285 | ||||||||||||
|
Liazon
|
| 37,000 | 819,999 | 856,999 | ||||||||||||
|
SOMS Technologies, LLC
|
| | 101,945 | 101,945 | ||||||||||||
|
|
||||||||||||||||
|
Total Purchases/Changes to Securities
and Non- Cash conversions
|
| 359,285 | 921,944 | 1,281,229 | ||||||||||||
|
|
||||||||||||||||
|
Repayments of Securities
|
||||||||||||||||
|
Gemcor II, LLC (Gemcor)
|
(71,162 | ) | | | (71,162 | ) | ||||||||||
|
Liazon
|
| (500,000 | ) | | (500,000 | ) | ||||||||||
|
|
||||||||||||||||
|
Total Repayments of Securities
|
(71,162 | ) | (500,000 | ) | | (571,162 | ) | |||||||||
|
Transfers within Level 3
|
| | | | ||||||||||||
|
Transfers in or out of Level 3
|
| | | | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Ending Balance, September 30, 2011, of
Level 3 Assets
|
$ | 342,435 | $ | 3,403,111 | $ | 17,951,446 | $ | 21,696,992 | ||||||||
|
|
||||||||||||||||
|
Amount of total gains or losses for the period included in changes in net assets attributable
to the change in unrealized gains or losses relating to assets still held at the reporting date and
reported within the net realized and unrealized gains or losses on investments in the
Condensed Consolidated Statement of Operations
|
$ | 3,696,431 | ||
|
|
||||
|
Amount of realized losses included in changes in net assets from operations for the
period reported above within the net realized and unrealized gains or losses on investments in the
Condensed Consolidated Statement of Operations
|
(2,074,131 | ) | ||
|
|
||||
|
|
||||
|
Change in unrealized gains or losses relating to assets still held at reporting date
|
$ | 1,622,300 | ||
|
|
||||
17
| Fair Value Measurements Using Significant | ||||||||||||||||
| Unobservable Inputs (Level 3) | ||||||||||||||||
| Venture Capital Investments | ||||||||||||||||
| Loan | Debt | Equity | ||||||||||||||
| Description | Investments | Investments | Investments | Total | ||||||||||||
|
Beginning Balance, December 31, 2009, of
Level 3 Assets
|
$ | 488,104 | $ | 3,487,120 | $ | 20,290,423 | $ | 24,265,647 | ||||||||
|
|
||||||||||||||||
|
Realized Gains or Losses included in net
change in net assets from operations
|
||||||||||||||||
|
Bioworks Inc. (Bioworks)
|
| | (49,830 | ) | (49,830 | ) | ||||||||||
|
Innov-X Systems Inc (Innovex)
|
| | 4,361,329 | 4,361,329 | ||||||||||||
|
|
||||||||||||||||
|
Total Realized Gains
|
| | 4,311,499 | 4,311,499 | ||||||||||||
|
|
||||||||||||||||
|
Unrealized gains or losses included in
net change in net assets from operations
|
||||||||||||||||
|
Bioworks
|
| | 56,000 | 56,000 | ||||||||||||
|
GridApp Systems Inc. (GridApp)
|
| | 295,935 | 295,935 | ||||||||||||
|
Innovex
|
| | (5,050,000 | ) | (5,050,000 | ) | ||||||||||
|
Niagara Dispensing Technologies, Inc.
(Niagara Dispensing)
|
| | (350,162 | ) | (350,162 | ) | ||||||||||
|
Photonics Products Group, Inc. (Photonics)
|
| | 2 | 2 | ||||||||||||
|
SOMS Technologies, LLC (SOMS)
|
| | 55,717 | 55,717 | ||||||||||||
|
|
||||||||||||||||
|
Total Unrealized Gains and Losses
|
| | (4,992,508 | ) | (4,992,508 | ) | ||||||||||
|
|
||||||||||||||||
|
Purchases of Securities/Changes to
Securities/Non-cash conversions
|
||||||||||||||||
|
EmergingMed.com, Inc. (Emerging Med)
|
| 216,712 | | 216,712 | ||||||||||||
|
GridApp
|
| | 481,772 | 481,772 | ||||||||||||
|
Mezmeriz, Inc. (Mezmeriz)
|
| | 21,509 | 21,509 | ||||||||||||
|
Microcision LLC (Microcision)
|
| 900,087 | | 900,087 | ||||||||||||
|
Mid America Brick (Mid America)
|
| | 800,000 | 800,000 | ||||||||||||
|
Niagara Dispensing
|
| 236,919 | | 236,919 | ||||||||||||
|
Rheonix, Inc. (Rheonix)
|
| | 500,000 | 500,000 | ||||||||||||
|
SOMS
|
| 15,897 | | 15,897 | ||||||||||||
|
|
||||||||||||||||
|
Total Purchases/Changes to
Securities and Non- Cash
conversions
|
| 1,369,615 | 1,803,281 | 3,172,896 | ||||||||||||
|
|
||||||||||||||||
|
Repayments of Securities
|
||||||||||||||||
|
Bioworks
|
| | (6,170 | ) | (6,170 | ) | ||||||||||
|
Gemcor II, LLC (Gemcor)
|
(54,827 | ) | (35,779 | ) | | (90,606 | ) | |||||||||
|
Innovex
|
| (250,000 | ) | (5,361,329 | ) | (5,611,329 | ) | |||||||||
|
|
||||||||||||||||
|
Total Repayments of Securities
|
(54,827 | ) | (285,779 | ) | (5,367,499 | ) | (5,708,105 | ) | ||||||||
|
|
||||||||||||||||
|
Transfers within Level 3
|
| (1,270,687 | ) | 1,270,687 | | |||||||||||
|
Transfers in or out of Level 3
|
| | | | ||||||||||||
|
|
||||||||||||||||
|
|
||||||||||||||||
|
Ending Balance, September 30, 2010, of
Level 3 Assets
|
$ | 433,277 | $ | 3,300,269 | $ | 17,315,883 | $ | 21,049,429 | ||||||||
|
|
||||||||||||||||
|
The amount of total gains or losses for the period included in earnings (or changes in net assets)
attributable to the change in unrealized gains or losses relating to assets still held
at the reporting date.
|
$ | (4,992,508 | ) | |
|
|
||||
|
Gains and losses (realized and unrealized) included in net decrease in net assets from operations
for the period above are reported as follows:
|
||||
|
|
||||
|
Net Gain (Loss) on sales and dispositions
|
4,311,499 | |||
|
|
||||
|
|
||||
|
Change in unrealized gains or losses relating to assets still held at reporting date
|
$ | (681,009 | ) | |
|
|
||||
18
| Nine months ended | Year ended | |||||||
| September 30, 2011 | December 31, | |||||||
| (Unaudited) | 2010 | |||||||
|
Income from investment operations (1):
|
||||||||
|
Investment income
|
$ | 0.13 | $ | 0.12 | ||||
|
Expenses
|
0.19 | 0.34 | ||||||
|
|
||||||||
|
Investment loss before income taxes
|
(0.06 | ) | (0.22 | ) | ||||
|
Income tax benefit
|
(0.02 | ) | (0.08 | ) | ||||
|
|
||||||||
|
Net investment loss
|
(0.04 | ) | (0.14 | ) | ||||
|
Net realized and unrealized gain on investments
|
0.16 | 0.12 | ||||||
|
|
||||||||
|
Increase (decrease) in net asset value
|
0.12 | (0.02 | ) | |||||
|
Net asset value, beginning of period, based on weighted average
shares
|
3.38 | 3.40 | ||||||
|
|
||||||||
|
Net asset value, end of period, based on weighted average shares
|
$ | 3.50 | $ | 3.38 | ||||
|
|
||||||||
|
Per share market price, end of period
|
$ | 2.80 | $ | 3.23 | ||||
|
|
||||||||
|
Total return based on market value
|
(13.31 | )% | (18.84 | %) | ||||
|
Total return based on net asset value
|
3.40 | % | (0.67 | )% | ||||
|
Supplemental data:
|
||||||||
|
Ratio of expenses before income taxes to average net assets
|
5.55 | % | 10.24 | % | ||||
|
Ratio of expenses including taxes to average net assets
|
5.04 | % | 7.87 | % | ||||
|
Ratio of net investment loss to average net assets
|
(1.13 | )% | (4.21 | )% | ||||
|
Portfolio turnover
|
6.2 | % | 16.5 | % | ||||
|
Net assets, end of period
|
$ | 23,834,747 | $ | 23,050,818 | ||||
|
Weighted average shares outstanding, end of period
|
6,818,934 | 6,818,934 | ||||||
| (1) | Per share data are based on weighted average shares outstanding and the results are rounded |
19
| Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
20
21
| (Decrease) | % (Decrease) | |||||||||||||||
| 9/30/11 | 12/31/10 | Increase | Increase | |||||||||||||
|
Total assets
|
$ | 30,206,268 | $ | 35,091,260 | $ | (4,884,992 | ) | (13.9 | %) | |||||||
|
Total liabilities
|
6,371,521 | 12,040,442 | (5,668,921 | ) | (47.1 | %) | ||||||||||
|
|
||||||||||||||||
|
Net assets
|
$ | 23,834,747 | $ | 23,050,818 | $ | 783,929 | 3.4 | % | ||||||||
|
|
||||||||||||||||
| (Decrease) | % (Decrease) | |||||||||||||||
| 9/30/11 | 12/31/10 | Increase | Increase | |||||||||||||
|
Investments, at cost
|
$ | 12,208,977 | $ | 13,573,041 | $ | (1,364,064 | ) | (10.0 | %) | |||||||
|
Unrealized appreciation, net
|
9,488,015 | 5,791,584 | 3,696,431 | 63.8 | % | |||||||||||
|
|
||||||||||||||||
|
Investments at fair value
|
$ | 21,696,992 | $ | 19,364,625 | $ | 2,332,367 | 12.0 | % | ||||||||
|
|
||||||||||||||||
| Amount | ||||
|
New Investments
|
||||
|
Liazon Corporation (Liazon)
|
$ | 819,999 | ||
|
Chequed.com, Inc (Chequed)
|
250,000 | |||
|
SOMS Technologies, LLC (SOMS)
|
101,945 | |||
|
|
||||
|
|
||||
|
Total of new investments during the nine months ended
September 30, 2011
|
$ | 1,171,944 | ||
|
|
||||
|
|
||||
|
Changes to Investments:
|
||||
|
Microcision LLC (Microcision) interest conversion
|
$ | 72,285 | ||
|
Liazon note accretion
|
37,000 | |||
|
|
||||
|
Total of changes to investments during the nine months ended
September 30, 2011
|
$ | 109,285 | ||
|
|
||||
|
|
||||
|
Investment Repaid/Sold or Liquidated:
|
||||
|
Niagara Dispensing Technologies, Inc. (Niagara Dispensing)
|
$ | (1,780,613 | ) | |
|
Liazon
|
(500,000 | ) | ||
|
Associates Interactive (Associates)
|
(293,518 | ) | ||
|
Gemcor II, LLC (Gemcor)
|
(71,162 | ) | ||
|
|
||||
|
Total of investments repaid, sold or liquidated during
the nine months ended September 30, 2011
|
$ | (2,645,293 | ) | |
|
|
||||
|
|
||||
|
Total change in investments, at cost,
during the nine months ended September 30, 2011
|
$ | (1,364,064 | ) | |
|
|
||||
22
| September 30, | September 30, | |||||||||||||||
| 2011 | 2010 | Increase | % Increase | |||||||||||||
|
Interest from portfolio companies
|
$ | 549,845 | $ | 523,921 | $ | 25,924 | 4.9 | % | ||||||||
|
Interest from other investments
|
26,909 | 15,959 | 10,950 | 68.6 | % | |||||||||||
|
Dividend and other investment
income
|
324,856 | 62,511 | 262,345 | 419.7 | % | |||||||||||
|
Other income
|
14,680 | 11,853 | 2,827 | 23.9 | % | |||||||||||
|
|
||||||||||||||||
|
Total investment income
|
$ | 916,290 | $ | 614,244 | $ | 302,046 | 49.2 | % | ||||||||
|
|
||||||||||||||||
| Interest | Investment | Year that Interest | ||||||||||
| Company | Rate | Cost | Accrual Ceased | |||||||||
|
G-Tec Natural Gas Systems (G-Tec)
|
8 | % | $ | 400,000 | 2004 | |||||||
23
| September 30, 2011 | September 30, 2010 | Decrease | % Decrease | |||||||||||||
|
Total Expenses
|
$ | 1,301,529 | $ | 1,625,482 | $ | (323,953 | ) | (19.9 | %) | |||||||
24
| September 30, | ||||
| 2011 | ||||
|
Reclass Niagara Dispensing to realized loss
|
$ | 1,729,112 | ||
|
Synacor, Inc. (Synacor)
|
1,531,999 | |||
|
Reclass Associates to a realized loss
|
293,519 | |||
|
Liazon
|
141,801 | |||
|
|
||||
|
Total change in net unrealized appreciation
during the nine months ended September 30, 2011
|
$ | 3,696,431 | ||
|
|
||||
| September 30, | ||||
| 2010 | ||||
|
GridApp Systems, Inc.
|
$ | 295,935 | ||
|
Bioworks, Inc.
|
56,000 | |||
|
SOMS
|
55,717 | |||
|
Photonics Products Group, Inc (Photonics)
|
2 | |||
|
Niagara Dispensing
|
(350,162 | ) | ||
|
Innov-X Systems, Inc. (Innovex)
|
(5,050,000 | ) | ||
|
|
||||
|
Total change in net unrealized appreciation
during the nine months ended September 30, 2010
|
$ | (4,992,508 | ) | |
|
|
||||
25
26
| Item 3. | Quantitative and Qualitative Disclosures about Market Risk |
| Item 4. | Controls and Procedures |
27
| Item 1. | Legal Proceedings |
| Item 1A. | Risk Factors |
| Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
| Item 3. | Defaults upon Senior Securities |
| Item 4. | (Removed and Reserved) |
| Item 5. | Other Information |
28
| (3 | )(i) |
Certificate of Incorporation of the Corporation, incorporated by
reference to Exhibit (a) (1) of Form N-2 filed with the Securities
Exchange Commission on April 22, 1997.
|
||
| (3 | )(ii) |
By-laws of the Corporation incorporated by reference to Exhibit (b) of
Form N-2 filed with the Securities Exchange Commission on April 22, 1997.
|
||
| (4 | ) |
Specimen certificate of common stock certificate,
incorporated by reference to Exhibit (b) of Form N-2 filed with the
Securities Exchange Commission on April 22, 1997.
|
||
| (10.1 | ) |
Employee Stock Option Plan incorporated by reference to Appendix B to
the Corporations definitive Proxy Statement filed on June 1, 2002.*
|
||
| (10.2 | ) |
Certificate of Incorporation of Rand Merger Corporation as filed by the
NY Department of State on 12/18/08 incorporated by reference to Exhibit
1(a) to Registration Statement No. 811-22276 on Form N-5 of Rand Capital
SBIC, Inc. filed with the SEC on 2/6/09.
|
||
| (10.3 | ) |
By-laws of Rand Capital SBIC, Inc. incorporated by reference to
Exhibit 2 to Registration Statement No. 811-22276 on Form N-5 of Rand
Capital SBIC, Inc. filed with the SEC on 2/6/09.
|
||
| (10.4 | ) |
Certificate of Merger of Rand Capital SBIC, L.P. and Rand Capital
Management, LLC into Rand Merger Corporation, as filed by the NY
Department of State on 12/18/08 incorporated by reference to Exhibit
1(b) to Registration Statement No. 811-22276 on Form N-5 of Rand Capital
SBIC, Inc. filed with the SEC on 2/6/09.
|
||
| (10.5 | ) |
Rand Capital Corporation Amended and Restated Profit Sharing Plan
applicable to Rand Capital SBIC, Inc. incorporated by reference to
Exhibit 7 to Registration Statement No. 811-22276 on Form N-5 of Rand
Capital SBIC, Inc. filed with the SEC on 2/6/09.*
|
||
| (31.1 | ) |
Certification of the Chief Executive Officer Pursuant to Rules
13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended,
filed herewith
|
||
| (31.2 | ) |
Certification of Chief Financial Officer Pursuant to Rules
13a-14(a)/15d-14(a) under the Securities Exchange Act of 1934, as amended,
filed herewith
|
||
| (32.1 | ) |
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Rand Capital Corporation furnished herewith
|
||
| (32.2 | ) |
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Rand Capital SBIC, Inc. furnished herewith
|
| * | Management contract or compensatory plan. |
29
|
RAND CAPITAL CORPORATION
|
||||
| By: | /s/ Allen F. Grum | |||
| Allen F. Grum, President | ||||
| By: | /s/ Daniel P. Penberthy | |||
| Daniel P. Penberthy, Treasurer | ||||
|
RAND CAPITAL SBIC, INC.
|
||||
| By: | /s/ Allen F. Grum | |||
| Allen F. Grum, President | ||||
| By: | /s/ Daniel P. Penberthy | |||
| Daniel P. Penberthy, Treasurer | ||||
30
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|